The goal of GLP-1 care is less visceral and liver fat while preserving muscle, not uncontrolled under-eating
Prior authorization typically requires documented attempts at diet, exercise, and behavioral interventions
Additionally, at Florida Plastic Surgery and Medspa, board-certified plastic surgeon Dr
Modern GLP-1 receptor agonists have demonstrated average weight loss of 15-20% of body weight with sustained treatment, representing a breakthrough in obesity pharmacotherapy that approaches the effectiveness of bariatric surgery
IN-VITRO LABORATORY RESEARCH : To the extent there is any information contained on the Website, it is strictly for the sole purposes of in-vitro laboratory research
While most are approved for the management of type 2 diabetes, some formulations, such as semaglutide (Wegovy) and tirzepatide (Zepbound), have also been approved for chronic weight management in adults with obesity or overweight